OMX Nordic 40
2.536,86
PKT
+0,45
PKT
+0,02
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.01.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 17.01.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 17.01.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 16.01.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.01.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 16.01.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 13.01.23 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 12.01.23 | Volvo (B) Sell | UBS AG | |
| 12.01.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 12.01.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 12.01.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.01.23 | Nokia Outperform | Credit Suisse Group | |
| 10.01.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.01.23 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | Volvo (B) Buy | Deutsche Bank AG | |
| 09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 09.01.23 | Novo Nordisk Sell | UBS AG | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.01.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 04.01.23 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
| 20.12.22 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.12.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 15.12.22 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 15.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 15.12.22 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. |